MedTrace Logo

A Descriptive Multicenter Investigation of Geriatrics Hotlines : A French Study

NCT03959475 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2020-07-14

No results posted yet for this study

Summary

In France, for general practitioners, the Emergency Hospitality Services (UAS) are the fastest and usual way to respond to the complexity of managing elderly polypathological patients. In 2013, the Regional Health Agencies proposed the creation of direct telephone assistance managed by geriatric doctors (geriatric hotlines) to promote interactions city - hospital. The aim of these hotlines is to improve the care pathways and health status of seniors. The objective of this study is to describe the care trajectories and health status of subjects over 75 years of age hospitalized in a short-term geriatric stay on the guidance of a Geriatric Hotline.

The study will take place over 24 months and in 7 French University Hospitallers Centres. The study will include all patients aged 75 and over, living at home or in an institution, who are hospitalized in a short-term geriatric ward on the guidance of a Hotline.

The results will show whether a management by the geriatric hotline is the most suitable for seniors, with an average length of stay probably shorter.

Conditions

  • Geriatric
  • Elderly

Sponsors & Collaborators

  • National School for Social Security

    collaborator UNKNOWN

  • Loire department

    collaborator UNKNOWN

  • Support and Education Technic Centre

    lead OTHER

Principal Investigators

  • Régis GONTHIER · CHU SAINT-ETIENNE

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-05
Primary Completion
2020-03-30
Completion
2020-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03959475 on ClinicalTrials.gov